Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL). Bone Marrow Transplant 2017 Feb;52(2):321-322

Date

11/29/2016

Pubmed ID

27892948

DOI

10.1038/bmt.2016.275

Scopus ID

2-s2.0-84997822155 (requires institutional sign-in at Scopus site)   2 Citations

Author List

Shah N, Rauenzahn S, Veltri L, Wen S, Craig M, Hamadani M, Kanate AS, Cumpston A

Author

Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Autografts
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Lymphoma, Non-Hodgkin
Male
Middle Aged
Retrospective Studies
Thiotepa
Time Factors